These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22227513)

  • 1. Epoprostenol-induced hypersplenism in portopulmonary hypertension.
    Touma W; Nayak RP; Hussain Z; Bacon BR; Kudva GC
    Am J Med Sci; 2012 Nov; 344(5):345-9. PubMed ID: 22227513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension.
    Findlay JY; Plevak DJ; Krowka MJ; Sack EM; Porayko MK
    Liver Transpl Surg; 1999 Sep; 5(5):362-5. PubMed ID: 10477835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
    Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
    Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
    Kato H; Katori T; Nakamura Y; Kawarasaki H
    Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
    Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB
    Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epoprostenol in the treatment of portopulmonary hypertension].
    Culafić D; Culafić-Vojinović V; Jesić R
    Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition.
    Tapper EB; Knowles D; Heffron T; Lawrence EC; Csete M
    Transplant Proc; 2009 Jun; 41(5):1969-71. PubMed ID: 19545770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series.
    Sussman N; Kaza V; Barshes N; Stribling R; Goss J; O'Mahony C; Zhang E; Vierling J; Frost A
    Am J Transplant; 2006 Sep; 6(9):2177-82. PubMed ID: 16796721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.
    Farber HW; Graven KK; Kokolski G; Korn JH
    J Rheumatol; 1999 May; 26(5):1195-6. PubMed ID: 10332990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment.
    Talwalkar JA; Swanson KL; Krowka MJ; Andrews JC; Kamath PS
    Gastroenterology; 2011 Nov; 141(5):1673-9. PubMed ID: 21723219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation.
    Raevens S; De Pauw M; Reyntjens K; Geerts A; Verhelst X; Berrevoet F; Rogiers X; Troisi RI; Van Vlierberghe H; Colle I
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):495-502. PubMed ID: 23242127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK; Bass NM; De Marco T; Merriman RB
    Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.
    Rafanan AL; Maurer J; Mehta AC; Schilz R
    Chest; 2000 Nov; 118(5):1497-500. PubMed ID: 11083710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol.
    Laving A; Khanna A; Rubin L; Ing F; Dohil R; Lavine JE
    J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):466-8. PubMed ID: 16205516
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension.
    Kuo PC; Johnson LB; Plotkin JS; Howell CD; Bartlett ST; Rubin LJ
    Transplantation; 1997 Feb; 63(4):604-6. PubMed ID: 9047158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
    Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
    Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
    Sugimachi K; Soejima Y; Morita K; Ueda S; Fukuhara T; Nagata S; Ikegami T; Taketomi A; Maehara Y
    Transplant Proc; 2009 Jun; 41(5):1976-8. PubMed ID: 19545772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience.
    Awdish RL; Cajigas HR
    Lung; 2013 Dec; 191(6):593-600. PubMed ID: 23979006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.